Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 11, Issue 1, Pages 139
Publisher
Springer Nature
Online
2012-11-09
DOI
10.1186/1475-2840-11-139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Energy intake and adiponectin gene expression
- (2011) Liping Qiao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pharmacological and non-pharmacological interventions to influence adipose tissue function
- (2011) Jan Westerink et al. Cardiovascular Diabetology
- Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study
- (2011) Yayoi Nishida et al. Cardiovascular Diabetology
- Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice
- (2011) P. W. Caton et al. DIABETES OBESITY & METABOLISM
- Association of Sirtuin 1 (SIRT1) Gene SNPs and Transcript Expression Levels With Severe Obesity
- (2011) Stephen J. Clark et al. Obesity
- Modulation of PPAR-γ by telmisartan protects the heart against myocardial infarction in experimental diabetes
- (2010) Sameer Goyal et al. CHEMICO-BIOLOGICAL INTERACTIONS
- SirT1 in muscle physiology and disease: lessons from mouse models
- (2010) M. Vinciguerra et al. Disease Models & Mechanisms
- Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
- (2010) Jiangyong Ouyang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1
- (2010) Masato Iwabu et al. NATURE
- AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
- (2009) Bei B. Zhang et al. Cell Metabolism
- Metabolic benefits from Sirt1 and Sirt1 activators
- (2009) Nilika Chaudhary et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
- (2009) Carles Cantó et al. CURRENT OPINION IN LIPIDOLOGY
- Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic β-cells
- (2009) Y. Saitoh et al. DIABETES & METABOLISM
- Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase
- (2009) O. Bourron et al. DIABETOLOGIA
- PPAR control: it's SIRTainly as easy as PGC
- (2009) Mary C Sugden et al. JOURNAL OF ENDOCRINOLOGY
- SirT1 Gain of Function Increases Energy Efficiency and Prevents Diabetes in Mice
- (2008) Alexander S. Banks et al. Cell Metabolism
- Tissue-specific regulation of SIRT1 by calorie restriction
- (2008) D. Chen et al. GENES & DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now